TenderDekho Logo
Closed GEM

Indian Army Department of Military Affairs Topical Pharmaceutical Tender Kannur Kerala 670001 2026 - MSME/Manufacture Licences & 25% Quantity Option

Bid Publish Date

20-May-2026, 11:47 am

Bid End Date

30-May-2026, 12:00 pm

EMD

₹187

Progress

RA
Issue20-May-2026, 11:47 am
Reverse Auction14-Jun-2026, 2:00 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

8717

Category

Betamethasone 0 point 1 percent w by w Cream Tube of 20 gm

Bid Type

Two Packet Bid

Categories 22

Tender Overview

  • Organization: Indian Army, Department Of Military Affairs. Product/Service: Wide range of topical dermatology and ophthalmic formulations including Betamethasone, Mupirocin, Miconazole, Clobetasol, TACrolimus ointments, anesthetic gels, antiseptic creams, and related ophthalmic gel products. Location: Kannur, Kerala (670001). Estimated Value/EMD: EMD ₹187; large catalog with 25% quantity variation option. Context: Tender seeks approved suppliers capable of supplying multiple medicated creams, ointments, gels, and pastes with drug licenses and manufacturing credentials. Differentiator: explicit option clause to adjust order quantity up to 25% during and after contract, subject to contracted rates. Unique aspect: extensive list of pharmaceutical formulations across multiple therapeutic categories in a single award. This procurement supports military healthcare provisioning and compliant drug distribution through licensed manufacturers.

Technical Specifications & Requirements

  • Product scope includes: ointments, creams, gels, pastes, and ophthalmic gels covering agents such as Betamethasone, Clobetasol, Mupirocin, Miconazole, Clindamycin, Desensitising pastes, Lignocaine, Gabapentin gel, Halobetasol, Tacrolimus, Povidone Iodine, Fusidic Acid, and Neomycin/Gentamicin blends.
  • Delivery/BOQ: BOQ lists 25 items; exact quantities not disclosed; ready for multi-item supply.
  • Vendor qualifications require: Drug licence, regional drug authority clearance, GST, PAN, Make-In-India certificate, distributor authorization, and OEM authorisation.
  • EMD/Submission: e-PBG for bills; EMD submitted by all non-MSME manufacturers; vendor performance certificates and turnover documentation required.
  • Compliance: Ensure drug manufacturing licence validity; vendor to be central/defense supplier; 3+ years experience with past performance evidence.
  • Delivery terms: Option to increase quantities up to 25%; minimum 30 days extension period for additional time; delivery schedule tied to last delivery order date.

Terms, Conditions & Eligibility

  • EMD: ₹187 (non-MSME); required to be submitted physically and online; DGN/GST/PAN and drug license/Trade license mandatory.
  • Experience: Minimum 3 years in similar drug supply; Past Performance certificate required.
  • Turnover: Bidder turnover certificate; MSME eligibility for manufacturing is applicable.
  • Documents: GST, PAN, Drug Licence, Trade Licence, Distributor Authorization, OEM authorizations, Make in India certificate, Affidavit, Past Performance, Experience Certificates.
  • Payment/Delivery: Delivery terms aligned with option clause; 25% quantity variation; timely payments per contract terms; e-PBG required for billing.
  • Penalties/Warranty: Not explicitly stated; penalties/LD likely per standard government terms; ensure compliance with ATC clauses.

Key Specifications

  • Product scope includes: Betamethasone 0.1% ointment; Mupirocin 2% ointment 5 g; Miconazole 2% cream 30 g; Clindamycin 1% with Adapalene 0.1% aloe gel 15 g; Clobetasol 0.05% ointment; Desensitising pastes 40-55 ml/g; Ophthalmic Hydroxy Methyl Cellulose 0.3% gel 10 g; Neomycin/Polymyxin/Bacitracin oint 5 g; Tacrolimus 0.03% 20 g; Triamcinolone 0.1% oral tube 5 g; Betamethasone 0.1% with Neomycin 0.5% oint 20 g; Clobetasol/Gentamicin/Miconazole 2%/Cream 15 g; Betamethasone 0.1% with Neomycin 0.5% w/w; Povidone Iodine 10% ointment 15 g; Fusidic Acid 2% + Clotrimazole 1% + Clobetasol 0.05% cream 15 g; Lignocaine 5% in gel; Gabapentin 6% in gel 30 g; Lactic acid 3%/Salicylic 3%/Urea 10% ointment 30 g; Betamethasone Dipropionate 0.05% w/w with Gentamicin 1 mg/g; others in list.

  • Standards/Certification expectations: Drug manufacturing licence; Regional Drug Controller clearance; Make in India certificate; GST/PAN validation; OEM/distributor authorisations.

Terms & Conditions

  • EMD amount: ₹187; payable with bid submission; non-MSME manufacturers required.

  • Quantity flexibility: up to 25% increase or during currency; delivery period adjustments with minimum 30 days.

  • Documentation: Drug licence, GST, PAN, experience and past performance certificates; Make in India and distributor authorisations required.

Important Clauses

Payment Terms

EMD submission required; e-PBG for billing; contract payments aligned with delivery and performance terms.

Delivery Schedule

Delivery starts after last delivery order; option quantity extensions governed by formula (additional time = (increased/original) × original days) with a minimum of 30 days.

Penalties/Liquidated Damages

Penalties to be applied as per standard government terms; specifics to be detailed in purchase contract and ATC.

Bidder Eligibility

  • Minimum 3 years experience in supplying similar pharmaceutical products

  • Central/Defence supplier status or eligible as per ATC

  • Manufacturing licence and regional drug authority clearance

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Item Category

Betamethasone 0 point 1 percent w by w Cream Tube of 20 gm , Mupirocin 2 percent Oint tube of 5 gm , Miconazole Nitrate 2 point 0 percent Cream Tube of 30 Gm , Clindamycin 1 percent and Adapalene 0 point 1 percent in Aloe Allantoin Gel based Tube of 15 gm , Clobetasol0 point 05 percent w by w and Salicylic Acid 3 point 5 percent w by w Oint Tube of 20 gm , Desensitising paste Tube of 40 to 55 ml or gm , Hydroxy Methyl Cellulose Ophthalmic Gel 0 point 3 percent Tube of 10 gm , Neomycin Sulphate Polymyxin B Sulphate and Bacitracin Zinc Oint Tube of 5 Gm , Tacrolimus oint 0 point 03 percent 20 gm tube , Triamcinolone Acetonide 0 point 1 percent for oral use tube of 5 gm , Clobetasol Propionate 0 point 05 percent and Neomycin Sulphate 0 point 50 percent Cream Tube of 20 Gm , Clobetasol Propionate 0 point 05 percent Gentamycin 0 point 1 percent and Miconozole Nitrate 2 point 0 percent Cream Tube of 15 Gm , Betamethasone 0 point 1 percent and Neomycin 0 point 5 percent Oint 20 gm , 0 point 05 percent Halobetasol Propionate Oint Tube of 15 gms , Lignocain 5 percent w by w and Gabapentin 6 percent w by w Gel Tube of 30 Gm , Betamethasone Dipropionate USP 0 point 05mg and Gentamycin Sulphate 1mg by gm tube of 5gm , Beclomethasone Dipropionate 0 point 05 percent and Salicylic Acid 3 point 0 percent Oint Tube of 20 Gm , Clobetasol Propionate 0 point 05 percent and Gentamycin 0 point 1 percent Cream Tube of 20 Gm , Chlorhexidine Gluconate 1 percent Metronidazole 1 percent and Lignocaine HCL 2 percent Mouth Gel Tube of 15 Gm , Betamethasone dipropionate 0 point 025 percent w by w Neomycin 0 point 5 percent w by w Clotrimazole 1 percent w by w cream tube of 20g , Povidone Iodine 10 percent Ointment Tube of 15 Gm , Fusidic Acid 2 percent Clotrimazole 1 percent and Clobetasol 0 point 05 percent Cream Tube of 15 Gm , Betamethasone Dipropianate 0 point 05 percent Oint Tube of 15 Gm , Tacrolimus 0 point 1 percent Ointment tube of 30 gm , Clobetasol Propionate 0 point 05 percent Lactic Acid 3 percent Salicylic Acid 3 percent and Urea 10 percent Oint 30Gm Tube

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENT

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 4

GeM-Bidding-9216093.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 25 Items Sign in for GEM prices

#1

Betamethasone 0 point 1 percent w by w Cream Tube of 20 gm

Patient Care

240 tube Delivery: 30 days
#2

Mupirocin 2 percent Oint tube of 5 gm

Patient Care

2,730 tube Delivery: 30 days
#3

Miconazole Nitrate 2 point 0 percent Cream Tube of 30 Gm

Patient Care

350 tube Delivery: 30 days
#4

Clindamycin 1 percent and Adapalene 0 point 1 percent in Aloe Allantoin Gel based Tube of 15 gm

Patient Care

21 tube Delivery: 30 days
#5

Clobetasol0 point 05 percent w by w and Salicylic Acid 3 point 5 percent w by w Oint Tube of 20 gm

Patient Care

540 tube Delivery: 30 days
#6

Desensitising paste Tube of 40 to 55 ml or gm

Patient Care

1,110 tube Delivery: 30 days
#7

Hydroxy Methyl Cellulose Ophthalmic Gel 0 point 3 percent Tube of 10 gm

Patient Care

30 tube Delivery: 30 days
#8

Neomycin Sulphate Polymyxin B Sulphate and Bacitracin Zinc Oint Tube of 5 Gm

Patient Care

110 tube Delivery: 30 days
#9

Tacrolimus oint 0 point 03 percent 20 gm tube

Patient Care

30 tube Delivery: 30 days
#10

Triamcinolone Acetonide 0 point 1 percent for oral use tube of 5 gm

Patient Care

160 tube Delivery: 30 days
#11

Clobetasol Propionate 0 point 05 percent and Neomycin Sulphate 0 point 50 percent Cream Tube of 20 Gm

Patient Care

240 tube Delivery: 30 days
#12

Clobetasol Propionate 0 point 05 percent Gentamycin 0 point 1 percent and Miconozole Nitrate 2 point 0 percent Cream Tube of 15 Gm

Patient Care

220 tube Delivery: 30 days
#13

Betamethasone 0 point 1 percent and Neomycin 0 point 5 percent Oint 20 gm

Patient Care

390 tube Delivery: 30 days
#14

0 point 05 percent Halobetasol Propionate Oint Tube of 15 gms

Patient Care

30 tube Delivery: 30 days
#15

Lignocain 5 percent w by w and Gabapentin 6 percent w by w Gel Tube of 30 Gm

Patient Care

120 tube Delivery: 30 days
#16

Betamethasone Dipropionate USP 0 point 05mg and Gentamycin Sulphate 1mg by gm tube of 5gm

Patient Care

186 tube Delivery: 30 days
#17

Beclomethasone Dipropionate 0 point 05 percent and Salicylic Acid 3 point 0 percent Oint Tube of 20 Gm

Patient Care

180 tube Delivery: 30 days
#18

Clobetasol Propionate 0 point 05 percent and Gentamycin 0 point 1 percent Cream Tube of 20 Gm

Patient Care

150 tube Delivery: 30 days
#19

Chlorhexidine Gluconate 1 percent Metronidazole 1 percent and Lignocaine HCL 2 percent Mouth Gel Tube of 15 Gm

Patient Care

90 tube Delivery: 30 days
#20

Betamethasone dipropionate 0 point 025 percent w by w Neomycin 0 point 5 percent w by w Clotrimazole 1 percent w by w cream tube of 20g

Patient Care

360 tube Delivery: 30 days
#21

Povidone Iodine 10 percent Ointment Tube of 15 Gm

Patient Care

631 tube Delivery: 30 days
#22

Fusidic Acid 2 percent Clotrimazole 1 percent and Clobetasol 0 point 05 percent Cream Tube of 15 Gm

Patient Care

360 tube Delivery: 30 days
#23

Betamethasone Dipropianate 0 point 05 percent Oint Tube of 15 Gm

Patient Care

240 tube Delivery: 30 days
#24

Tacrolimus 0 point 1 percent Ointment tube of 30 gm

Patient Care

95 tube Delivery: 30 days
#25

Clobetasol Propionate 0 point 05 percent Lactic Acid 3 percent Salicylic Acid 3 percent and Urea 10 percent Oint 30Gm Tube

Patient Care

104 tube Delivery: 30 days

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

GST Registration Certificate

2

PAN Card

3

Drug Licence and Trade Licence

4

Distributor Authorisation Certificate

5

OEM Manufacturer Authorisation

6

Make in India Certificate

7

Experience Certificates (minimum 3 years)

8

Past Performance Certificate (minimum 3 years)

9

Bidder Turnover Certificate (CA-certified)

10

Affidavit of criminal/fraudulence clearance

11

MSME Certificate (if applicable)

12

e-PBG submission

Reverse Auction Schedule

Completed

Start

14-Jun-2026, 2:00 pm

End

15-Jun-2026, 2:00 pm

Duration: 24 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

Key insights about KERALA tender market

How to participate in the Indian Army dermatology drug tender in Kannur Kerala

To participate, bidders must meet eligibility: 3+ years in similar drug supply, valid drug licence, GST/PAN, Make in India, OEM/distributor authorisation, and provide experience and past performance certificates. Submit EMD ₹187 (non-MSME), and upload documents in mandatory columns. Ensure Make in India and regional drug authority compliance for all listed products.

What documents are required for the Kerala pharma tender submission

Required documents include GST Registration, PAN Card, Drug Licence and Trade Licence, Distributor Authorisation, OEM Authorisation, Make in India Certificate, Experience Certificates (3+ years), Past Performance Certificate, Bidder Turnover Certificate, and Affidavit. EMD must be submitted; e-PBG is required for post-delivery billing.

Which items are included in the BOQ for the Indian Army tender in Kannur

The BOQ encompasses 25 items covering topical creams, ointments, gels, desensitising pastes, and ophthalmic gels. Specific active ingredients include Betamethasone, Clobetasol, Mupirocin, Miconazole, Tacrolimus, Clindamycin with Adapalene, and other combination products; exact quantities are defined per item in the BOQ.

What are the delivery extension rules for quantity variations

Delivery extension allows a 25% quantity variation during/after contract at contracted rates. Additional time is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days; if original period is less than 30 days, extension equals the original period.

What are the EMD requirements and payment terms for this tender

EMD amount is ₹187; submission required both physically and on the Gem portal unless MSME. Payment terms link to delivery and e-PBG; ensure timely submission of post-delivery documentation and compliance with ATC terms for payment processing.

What licenses and certifications are mandatory for drug suppliers

Mandatory licenses include Drug Licence, Regional Drug Controller clearance, GST, PAN, and Make in India certificate. Also required are Distributor Authorisation and OEM Authorisation from the drug manufacturer; ensure the vendor is a central/defence supplier with valid turnover proof.

How to verify Make in India and OEM compliance for this bid

Verify Make in India certificate validity and manufacturer’s OEM authorisation aligned with listed products. Cross-check that the drug licences cover the exact formulation lines, and ensure the distributor is authorised by the original drug manufacturer. Documented verification is required in the ATC-compliant bid submission.

What standards and product scope are applicable in this Indian Army tender

The tender covers 25 pharmaceutical products, including Betamethasone, Mupirocin, Miconazole, Clobetasol, and Tacrolimus formulations; suppliers must provide drug licences, GST, PAN, and Make in India certification, with 3+ years of relevant experience and past performance proofs.